511509 VIVOBIOT

Vivo Bio Tech Share Price

 

 

Start SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹33
  • High
  • ₹34
  • 52 Week Low
  • ₹31
  • 52 Week High
  • ₹57
  • Open Price₹33
  • Previous Close₹33
  • Volume24,719

Investment Returns

  • Over 1 Month -9.43%
  • Over 3 Month -6.31%
  • Over 6 Month -4.02%
  • Over 1 Year -11.85%

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 54
  • P/B Ratio
  • 0.9
  • Average True Range
  • 1.4
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.96
  • RSI
  • 37.89
  • MFI
  • 18.15

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹33.70
+ 0.88 (2.68%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹34.77
  • 50 Day
  • ₹35.98
  • 100 Day
  • ₹36.61
  • 200 Day
  • ₹37.33

Resistance and Support

33.41 Pivot Speed
  • R3 35.26
  • R2 34.61
  • R1 34.06
  • S1 32.86
  • S2 32.21
  • S3 31.66

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results
2025-05-19 Audited Results
2025-01-09 Quarterly Results
2024-11-21 Employees Stock Option Plan

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

35.16%
32.3%
32.54%

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹33 As on 09 November, 2025 | 12:12

The Market Cap of Vivo Bio Tech is ₹54.4 Cr As on 09 November, 2025 | 12:12

The P/E ratio of Vivo Bio Tech is 6.4 As on 09 November, 2025 | 12:12

The PB ratio of Vivo Bio Tech is 0.9 As on 09 November, 2025 | 12:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23